Healthcare2 min reading time
Moderna's mRNA flu shot earns FDA approval after rollercoaster review
Ars Technica
Read full postModerna's mRNA flu vaccine, mFLUSIVA, has received FDA approval, marking a milestone for mRNA technology in flu prevention. The vaccine offers faster production and potential benefits over traditional flu shots but faces uncertainty due to a stalled CDC advisory panel and unclear insurance coverage.



